Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex

Molecular and Cellular Biology

Volumn 20, Issue 12, 2000, Pages 4455-4461

  Nekrep, Nada ^a   Jabrane Ferrat, Nabila ^a   Peterlin, B Matija ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN SUBUNIT; REGULATORY FACTOR X; UNCLASSIFIED DRUG;

ARTICLE; BARE LYMPHOCYTE SYNDROME; CONTROLLED STUDY; DNA BINDING; GENE MUTATION; IMMUNE DEFICIENCY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN PROTEIN INTERACTION;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); SEVERE COMBINED IMMUNODEFICIENCY; TRANSCRIPTION FACTORS;

EID: 0034086225     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.12.4455-4461.2000     Document Type: Article

References (28)

1. Alberts, A. S., and R. Treisman. 1998. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J. 17:4075-4085.
2. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681-715.
3. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107-113.
4. Cogswell, J. P., N. Zeleznik-Le, and J. P. Ting. 1991. Transcriptional regulation of the HLA-DRA gene. Crit. Rev. Immunol. 11:87-112.
5. Cress, W. D., and S. J. Triezenberg. 1991. Critical structural elements of the VP16 transcriptional activation domain. Science 251:87-90.
6. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
7. Douhan, J., III, I. Hauber, M. M. Eibl, and L. H. Glimcher. 1996. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains. J. Exp. Med. 183:1063-1069.
8. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045-1055.
9. Fondaneche, M. C., J. Villard, W. Wiszniewski, E. Jouanguy, A. Etzioni, F. Le Deist, A. Peijnenburg, J. L. Casanova, W. Reith, B. Mach, A. Fischer, and B. Lisowska-Grospierre. 1998. Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum. Mol. Genet. 7:879-885.
10. Fontes, J. D., N. Jabrane-Ferrat, and B. M. Peterlin. 1997. Assembly of functional regulatory complexes on MHC class II promoters in vivo. J. Mol. Biol. 270:336-345.
11. Fontes, J. D., S. Kanazawa, N. Nekrep, and B. M. Peterlin. 1999. The class II transactivator CIITA is a transcriptional integrator. Microbes Infect. 1:863-869.
12. Ghosh, S., M. J. Selby, and B. M. Peterlin. 1993. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J. Mol. Biol. 234:610-619.
13. Gladstone, P., and D. Pious 1978. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature 271:459-461.
14. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.
15. Jabrane-Ferrat, N., J. D. Fontes, J. M. Boss, and B. M. Peterlin. 1996. Complex architecture of major histocompatibiliry complex class II promoters: reiterated motifs and conserved protein-protein interactions. Mol. Cell. Biol. 16:4683-4690.
16. Jabrane-Ferrat, N., and B. M. Peterlin. 1994. Ets-1 activates the DRA promoter in B cells. Mol. Cell. Biol. 14:7314-7321.
17. Lisowska-Grospierre, B., M. C. Fondaneche, M. P. Rols, C. Griscelli, and A. Fischer. 1994. Two complementation groups account for most cases of inherited MHC class II deficiency. Hum. Mol. Genet. 3:953-958.
18. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
19. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
20. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273-277.
21. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the hare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153-162. (Erratum, 10:399.)
22. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
23. Sadowski, I., and M. Ptashne. 1989. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539.
24. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II hare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330-6334.
25. Steimle, V., B. Durand, E. Barras, M. Zufferty, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-hinding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021-1032.
26. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146.
27. Villard, J., B. Mach, and W. Reith. 1997. MHC class II deficiency: definition of a new complementation group. Immunobiology 198:264-272.
28. Westerheide, S. D., and J. M. Boss. 1999. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. Nucleic Acids Res. 27:1635-1641.